GlassScriptPhysician profile
Matthew Boyd Baker
NPI 1316975782
$1,477.27
in general payments reported to CMS, 2019-2025
17 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.58 · 2020: $77.83 · 2021: $109 · 2022: $144 · 2023: $417 · 2024: $476 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,047.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $267.99 | 2023 | Lupkynis |
| Astrazeneca Pharmaceuticals LP | $198.23 | 2024-2025 | Airsupra |
| Takeda Pharmaceuticals U.S.A., INC. | $156.37 | 2020-2022 | |
| Lilly USA, LLC | $137.81 | 2023-2025 | Mounjaro, Zepbound |
| Exact Sciences Corporation | $128.90 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $125.80 | 2019-2023 | |
| Smith+Nephew, INC. | $93.49 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Sobi, INC | $90.77 | 2020-2023 | |
| Sanofi Pasteur INC. | $51.70 | 2022-2025 | |
| Novo Nordisk INC | $50.74 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $44.03 | 2022-2025 | Shingrix |
| Merck Sharp & Dohme LLC | $34.72 | 2022-2024 | Gardasil, Vaxelis, Gardasil 9 |
| Sanofi-Aventis U.S. LLC | $28.42 | 2024 | |
| Motiva USA, LLC | $24.93 | 2025 | |
| Genentech USA, INC. | $17.50 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $15.06 | 2019 | |
| Medtronic Vascular, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.